Blood and Cystic Fluid From Patients Undergoing Surgery for Worrisome Pancreatic Cysts

Part of paid clinical trials in Newport Beach, California.

Sponsor
Translational Genomics Research Institute
Study ID
NCT07767227
Status
Recruiting
Apply to this trial

Conditions

  • Pancreatic Cyst

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this study is to collect biospecimens (blood and cystic fluid) and data from participants who have a pancreatic cyst that requires surgical resection. The blood and fluid samples will be analyzed for research into DNA, RNA, and proteins.

Key Dates

First listed
Aug 17, 2026
Start date
Feb 3, 2025
Status verified
Jul 2026
Primary completion
Dec 31, 2027
Completion
Mar 31, 2028

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Pancreatic cyst
    Patients who are or will be scheduled for surgical resection of their worrisome pancreatic cyst as part of their clinically indicated care.

Primary Outcome Measure

Characterize the miRNA and protein signatures in exosomes derived from blood and cyst fluids in patients with worrisome cystic pancreatic tumors [ Time Frame: At enrollment ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Hoag Family Cancer InstituteNewport BeachCalifornia92663
Michael Demeure, MD
[email protected]
949-764-4577
Piedmont HealthCareAtlantaGeorgia30309
Andrew Page, MD
[email protected]
(404) 605-7100

Find similar trials in Newport Beach, CA

By research site
Hoag Family Cancer Institute· Newport Beach, CAPiedmont HealthCare· Atlanta, GA

Related Studies